tiprankstipranks
Advertisement
Advertisement

CTKB Stock Latest News

Cytek Biosciences price target lowered to $5 from $5.50 at Morgan Stanley
The FlyCytek Biosciences price target lowered to $5 from $5.50 at Morgan Stanley
1d ago
CTKB
Cytek: Solid Q2 Beat and Modest Outlook Raise, But Regional and Profitability Risks Justify Hold Rating
PremiumRatings
Cytek: Solid Q2 Beat and Modest Outlook Raise, But Regional and Profitability Risks Justify Hold Rating
3d ago
CTKB
Cytek Biosciences reports Q2 EPS (9c), consensus (2c)
PremiumThe Fly
Cytek Biosciences reports Q2 EPS (9c), consensus (2c)
3d ago
CTKB
Cytek Biosciences sees FY26 revenue $207M-$212M, consensus $208.83M
PremiumThe Fly
Cytek Biosciences sees FY26 revenue $207M-$212M, consensus $208.83M
3d ago
CTKB
Cytek Biosciences Announces Chief Legal Officer Transition
PremiumCompany Announcements
Cytek Biosciences Announces Chief Legal Officer Transition
1M ago
8K
CTKB
Cytek Biosciences Stockholders Back Board, Pay and Auditor
PremiumCompany AnnouncementsCytek Biosciences Stockholders Back Board, Pay and Auditor
2M ago
8K
CTKB
S&P SmallCap 600 announces additions, deletions for quarterly rebalance
Premium
The Fly
S&P SmallCap 600 announces additions, deletions for quarterly rebalance
2M ago
CPB
EBC
Cytek Biosciences Announces Resignation of Senior Sales Executive
Premium
Company Announcements
Cytek Biosciences Announces Resignation of Senior Sales Executive
2M ago
8K
CTKB
Cytek Biosciences price target lowered to $4.75 from $5.50 at Stephens
PremiumThe Fly
Cytek Biosciences price target lowered to $4.75 from $5.50 at Stephens
3M ago
CTKB
Cytek Biosciences price target lowered to $5.50 from $6 at Morgan Stanley
PremiumThe Fly
Cytek Biosciences price target lowered to $5.50 from $6 at Morgan Stanley
3M ago
CTKB
Cytek Biosciences Faces Rising Risk From U.S.–China Trade Tensions and Tariff Pressures
PremiumCompany Announcements
Cytek Biosciences Faces Rising Risk From U.S.–China Trade Tensions and Tariff Pressures
3M ago
CTKB
Cytek Biosciences Balances Growth Momentum With Cost Pressures
PremiumCompany Announcements
Cytek Biosciences Balances Growth Momentum With Cost Pressures
3M ago
CTKB
Cytek Maintained at Hold as Risk‑Reward Stays Balanced; $5 Price Target Reaffirmed
PremiumRatingsCytek Maintained at Hold as Risk‑Reward Stays Balanced; $5 Price Target Reaffirmed
3M ago
CTKB
Cytek Biosciences Balances Growth With Margin Strain
Premium
Company Announcements
Cytek Biosciences Balances Growth With Margin Strain
5M ago
CTKB
Cytek Biosciences reports preliminary Q4 revenue $62M, consensus $56.99M
Premium
The Fly
Cytek Biosciences reports preliminary Q4 revenue $62M, consensus $56.99M
7M ago
CTKB
Cytek Biosciences price target raised to $5 from $4 at TD Cowen
PremiumThe Fly
Cytek Biosciences price target raised to $5 from $4 at TD Cowen
7M ago
CTKB
Cytek Biosciences assumed with an Equal Weight at Morgan Stanley
PremiumThe Fly
Cytek Biosciences assumed with an Equal Weight at Morgan Stanley
8M ago
CTKB
Cytek Biosciences price target lowered to $7.50 from $8 at Piper Sandler
PremiumThe Fly
Cytek Biosciences price target lowered to $7.50 from $8 at Piper Sandler
9M ago
CTKB
Cytek Biosciences Earnings Call: Mixed Sentiment and Growth
PremiumCompany Announcements
Cytek Biosciences Earnings Call: Mixed Sentiment and Growth
9M ago
CTKB
Cytek Biosciences Reports Modest Revenue Growth in Q3 2025
PremiumCompany AnnouncementsCytek Biosciences Reports Modest Revenue Growth in Q3 2025
9M ago
CTKB
Cautious Hold on Cytek Biosciences Amid Market Stagnation and Growth Uncertainty
Premium
Ratings
Cautious Hold on Cytek Biosciences Amid Market Stagnation and Growth Uncertainty
9M ago
CTKB
Cytek Biosciences backs FY25 revenue view $196M-$205M, consensus $195.95M
Premium
The Fly
Cytek Biosciences backs FY25 revenue view $196M-$205M, consensus $195.95M
9M ago
CTKB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >